Application of the linear-quadratic model to myelotoxicity associated with radioimmunotherapy View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1996-08

AUTHORS

Richard B. Wilder, Gerald L. DeNardo, Sui Sheri, John F. Fowler, Barry W. Wessels, Sally J. DeNardo

ABSTRACT

The purposes of this study were: (1) to use the linear-quadratic model to determine time-dependent biologically effective doses (BEDs) that were delivered to the bone marrow by multiple infusions of radiolabeled antibodies, and (2) to determine whether granulocyte and platelet counts correlate better with BED than administered radioactivity, which does not take stem cell repopulation, i.e., time, into consideration. Twenty patients with B-cell malignancies that had progressed despite intensive chemotherapy and who had a significant number of malignant cells in their bone marrow were treated with multiple 0.7-3.7 GBq/m2 (18-100 mCi/m2) intravenous infusions of Lym-1, a murine monoclonal antibody that binds to a tumour-associated antigen, labeled with iodine-131. Granulocyte and platelet counts were measured in order to assess bone marrow toxicity. BEDs were calculated according to the formula: BED=D(1+gD/(alpha/beta))-0.693(Tn-Tk)/alphaTp, where D represents the absorbed dose of radiation delivered to the red marrow by penetrating emissions of 131I throughout the whole body and nonpenetrating emissions of 131I in the blood and bone marrow, g is a factor that depends on the duration of irradiation relative to the repair half-life of human bone marrow, alpha is the coefficient of nonrepairable damage per Gy, beta is the coefficient of repairable damage per Gy2, Tn is the time required to reach the granulocyte or platelet count nadir after an 131I-Lym-1 infusion, Tk is the time at which bone marrow proliferation begins after the start of treatment and Tp is the doubling time of the bone marrow after the granulocyte or platelet count nadir has been reached. The cumulative 131I-Lym-1 radioactivity administered to each patient was calculated. Biologically effective doses from multiple 131I-Lym-1 infusions were summated in order to arrive at a total BED for each patient. There was a weak association between granulocyte and platelet counts and radioactivity (the correlation coefficients were -0.23 and -0.60, respectively). Likewise, there was a weak association between granulocyte and platelet counts and BED (the correlation coefficients were -0.27 and -0.40, respectively). The attempt to take bone marrow absorbed doses and overall treatment time into consideration with the linear-quadratic model did not produce a stronger association than was observed between peripheral blood counts and administered radioactivity. The association between granulocyte and platelet counts and BED may have been weakened by several factors, including variable bone marrow reserve at the start of 131I-Lym-1 therapy and the delivery of heterogeneous absorbed doses of radiation to the bone marrow. More... »

PAGES

953-957

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/bf01084370

DOI

http://dx.doi.org/10.1007/bf01084370

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1013405250

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/8753685


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Agranulocytosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Bone Marrow", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dose-Response Relationship, Radiation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Granulocytes", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Iodine Radioisotopes", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Leukemia, Lymphocytic, Chronic, B-Cell", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Leukocyte Count", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Linear Models", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lymphoma, Non-Hodgkin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Platelet Count", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Radioimmunotherapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Thrombocytopenia", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Time Factors", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "UC Davis Health System", 
          "id": "https://www.grid.ac/institutes/grid.416958.7", 
          "name": [
            "Department of Radiation Oncology, U.C. Davis Cancer Center, 4501 X St., Ste. G-126, 95817, Sacramento, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wilder", 
        "givenName": "Richard B.", 
        "id": "sg:person.01003154035.77", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01003154035.77"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of California Davis Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.413079.8", 
          "name": [
            "Department of Internal Medicine, University of California Davis Medical Center, Sacramento, California, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "DeNardo", 
        "givenName": "Gerald L.", 
        "id": "sg:person.07427223257.57", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07427223257.57"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of California Davis Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.413079.8", 
          "name": [
            "Department of Internal Medicine, University of California Davis Medical Center, Sacramento, California, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sheri", 
        "givenName": "Sui", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "UW Carbone Cancer Center", 
          "id": "https://www.grid.ac/institutes/grid.412639.b", 
          "name": [
            "Departments of Human Oncology and Medical Physics, University of Wisconsin Clinical Cancer Center, Madison, Wisconsin, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Fowler", 
        "givenName": "John F.", 
        "id": "sg:person.015350762352.16", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015350762352.16"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "George Washington University Hospital", 
          "id": "https://www.grid.ac/institutes/grid.411841.9", 
          "name": [
            "Division of Radiation Oncology and Biophysics, George Washington University Medical Center, Washington, D.C., USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wessels", 
        "givenName": "Barry W.", 
        "id": "sg:person.01122351054.42", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01122351054.42"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of California Davis Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.413079.8", 
          "name": [
            "Department of Internal Medicine, University of California Davis Medical Center, Sacramento, California, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "DeNardo", 
        "givenName": "Sally J.", 
        "id": "sg:person.01135077736.53", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01135077736.53"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1097/00003072-199502000-00005", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007371084"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00003072-199502000-00005", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007371084"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00003072-199502000-00005", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007371084"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/1097-0142(19940201)73:3+<1038::aid-cncr2820731343>3.0.co;2-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010988824"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00006231-199307000-00012", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028906005"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00006231-199307000-00012", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028906005"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0167-8140(90)90152-m", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029026126"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bjc.1986.16", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029332670", 
          "https://doi.org/10.1038/bjc.1986.16"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bjc.1986.16", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029332670", 
          "https://doi.org/10.1038/bjc.1986.16"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0167-8140(85)80046-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041530437"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/ijc.2910410819", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042188204"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0360-3016(90)90467-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044804676"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1259/0007-1285-62-735-241", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064557430"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1259/0007-1285-62-740-679", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064557601"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1076202820", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1079799337", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1079811328", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1081838744", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082585424", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1996-08", 
    "datePublishedReg": "1996-08-01", 
    "description": "The purposes of this study were: (1) to use the linear-quadratic model to determine time-dependent biologically effective doses (BEDs) that were delivered to the bone marrow by multiple infusions of radiolabeled antibodies, and (2) to determine whether granulocyte and platelet counts correlate better with BED than administered radioactivity, which does not take stem cell repopulation, i.e., time, into consideration. Twenty patients with B-cell malignancies that had progressed despite intensive chemotherapy and who had a significant number of malignant cells in their bone marrow were treated with multiple 0.7-3.7 GBq/m2 (18-100 mCi/m2) intravenous infusions of Lym-1, a murine monoclonal antibody that binds to a tumour-associated antigen, labeled with iodine-131. Granulocyte and platelet counts were measured in order to assess bone marrow toxicity. BEDs were calculated according to the formula: BED=D(1+gD/(alpha/beta))-0.693(Tn-Tk)/alphaTp, where D represents the absorbed dose of radiation delivered to the red marrow by penetrating emissions of 131I throughout the whole body and nonpenetrating emissions of 131I in the blood and bone marrow, g is a factor that depends on the duration of irradiation relative to the repair half-life of human bone marrow, alpha is the coefficient of nonrepairable damage per Gy, beta is the coefficient of repairable damage per Gy2, Tn is the time required to reach the granulocyte or platelet count nadir after an 131I-Lym-1 infusion, Tk is the time at which bone marrow proliferation begins after the start of treatment and Tp is the doubling time of the bone marrow after the granulocyte or platelet count nadir has been reached. The cumulative 131I-Lym-1 radioactivity administered to each patient was calculated. Biologically effective doses from multiple 131I-Lym-1 infusions were summated in order to arrive at a total BED for each patient. There was a weak association between granulocyte and platelet counts and radioactivity (the correlation coefficients were -0.23 and -0.60, respectively). Likewise, there was a weak association between granulocyte and platelet counts and BED (the correlation coefficients were -0.27 and -0.40, respectively). The attempt to take bone marrow absorbed doses and overall treatment time into consideration with the linear-quadratic model did not produce a stronger association than was observed between peripheral blood counts and administered radioactivity. The association between granulocyte and platelet counts and BED may have been weakened by several factors, including variable bone marrow reserve at the start of 131I-Lym-1 therapy and the delivery of heterogeneous absorbed doses of radiation to the bone marrow.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/bf01084370", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.2435561", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1297401", 
        "issn": [
          "1619-7070", 
          "1619-7089"
        ], 
        "name": "European Journal of Nuclear Medicine and Molecular Imaging", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "8", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "23"
      }
    ], 
    "name": "Application of the linear-quadratic model to myelotoxicity associated with radioimmunotherapy", 
    "pagination": "953-957", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "3fdc86c4fb796d02169d96256b60dedac2b6c830aada1ae7e6a4ec55709ae0b3"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "8753685"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "7606882"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/bf01084370"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1013405250"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/bf01084370", 
      "https://app.dimensions.ai/details/publication/pub.1013405250"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T13:33", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000370_0000000370/records_46769_00000000.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007/BF01084370"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/bf01084370'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/bf01084370'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/bf01084370'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/bf01084370'


 

This table displays all metadata directly associated to this object as RDF triples.

211 TRIPLES      21 PREDICATES      58 URIs      35 LITERALS      23 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/bf01084370 schema:about N0b5195102696497fabb3d83a39a5c320
2 N0ffd3cd6fe644a72beaebcd13e246197
3 N16a91c07477842d5b01fbf8e33aaf1ca
4 N1c4f47f2171d422b8f03c8237340f18d
5 N250abead97a14b54afef74d90fd9e944
6 N34cae762eb9c4f66a2dfe2024a9491c7
7 N3e9a134ab19a4d919cd8afe7377aa3a4
8 N3f0b6b7223e445f192cc1fe1b85fef4c
9 N44f58052b9264f93950d7e1bfea2612e
10 N45d3a2d3bf3e40259f4fc361fa7b4846
11 N5bcf7c9ea7114511ad803f1f8962d2f2
12 Na43594f076e54d0b9b5d9c8038f69ab6
13 Na51802e56b914af6807c40965b05800d
14 Nd59e0710947a4a50888b3c1ac373676a
15 anzsrc-for:11
16 anzsrc-for:1112
17 schema:author Nefcecbf3440c416fb36be28618fd525d
18 schema:citation sg:pub.10.1038/bjc.1986.16
19 https://app.dimensions.ai/details/publication/pub.1076202820
20 https://app.dimensions.ai/details/publication/pub.1079799337
21 https://app.dimensions.ai/details/publication/pub.1079811328
22 https://app.dimensions.ai/details/publication/pub.1081838744
23 https://app.dimensions.ai/details/publication/pub.1082585424
24 https://doi.org/10.1002/1097-0142(19940201)73:3+<1038::aid-cncr2820731343>3.0.co;2-8
25 https://doi.org/10.1002/ijc.2910410819
26 https://doi.org/10.1016/0167-8140(90)90152-m
27 https://doi.org/10.1016/0360-3016(90)90467-x
28 https://doi.org/10.1016/s0167-8140(85)80046-3
29 https://doi.org/10.1097/00003072-199502000-00005
30 https://doi.org/10.1097/00006231-199307000-00012
31 https://doi.org/10.1259/0007-1285-62-735-241
32 https://doi.org/10.1259/0007-1285-62-740-679
33 schema:datePublished 1996-08
34 schema:datePublishedReg 1996-08-01
35 schema:description The purposes of this study were: (1) to use the linear-quadratic model to determine time-dependent biologically effective doses (BEDs) that were delivered to the bone marrow by multiple infusions of radiolabeled antibodies, and (2) to determine whether granulocyte and platelet counts correlate better with BED than administered radioactivity, which does not take stem cell repopulation, i.e., time, into consideration. Twenty patients with B-cell malignancies that had progressed despite intensive chemotherapy and who had a significant number of malignant cells in their bone marrow were treated with multiple 0.7-3.7 GBq/m2 (18-100 mCi/m2) intravenous infusions of Lym-1, a murine monoclonal antibody that binds to a tumour-associated antigen, labeled with iodine-131. Granulocyte and platelet counts were measured in order to assess bone marrow toxicity. BEDs were calculated according to the formula: BED=D(1+gD/(alpha/beta))-0.693(Tn-Tk)/alphaTp, where D represents the absorbed dose of radiation delivered to the red marrow by penetrating emissions of 131I throughout the whole body and nonpenetrating emissions of 131I in the blood and bone marrow, g is a factor that depends on the duration of irradiation relative to the repair half-life of human bone marrow, alpha is the coefficient of nonrepairable damage per Gy, beta is the coefficient of repairable damage per Gy2, Tn is the time required to reach the granulocyte or platelet count nadir after an 131I-Lym-1 infusion, Tk is the time at which bone marrow proliferation begins after the start of treatment and Tp is the doubling time of the bone marrow after the granulocyte or platelet count nadir has been reached. The cumulative 131I-Lym-1 radioactivity administered to each patient was calculated. Biologically effective doses from multiple 131I-Lym-1 infusions were summated in order to arrive at a total BED for each patient. There was a weak association between granulocyte and platelet counts and radioactivity (the correlation coefficients were -0.23 and -0.60, respectively). Likewise, there was a weak association between granulocyte and platelet counts and BED (the correlation coefficients were -0.27 and -0.40, respectively). The attempt to take bone marrow absorbed doses and overall treatment time into consideration with the linear-quadratic model did not produce a stronger association than was observed between peripheral blood counts and administered radioactivity. The association between granulocyte and platelet counts and BED may have been weakened by several factors, including variable bone marrow reserve at the start of 131I-Lym-1 therapy and the delivery of heterogeneous absorbed doses of radiation to the bone marrow.
36 schema:genre research_article
37 schema:inLanguage en
38 schema:isAccessibleForFree false
39 schema:isPartOf N44d8548788064c4fae5efb434d99279e
40 Ne7e9c8f11cfe48dbaeae81d0dd11183c
41 sg:journal.1297401
42 schema:name Application of the linear-quadratic model to myelotoxicity associated with radioimmunotherapy
43 schema:pagination 953-957
44 schema:productId N0e6879e4b16c4ba0be24687b59aab277
45 N254e1cd2208e4825b669f65509a78cba
46 N30145b7544eb435fb3457a187ddfb58d
47 N7d91a97db9024526abf7233bcae51260
48 N86cbe7b55dd841c080ff38589c548442
49 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013405250
50 https://doi.org/10.1007/bf01084370
51 schema:sdDatePublished 2019-04-11T13:33
52 schema:sdLicense https://scigraph.springernature.com/explorer/license/
53 schema:sdPublisher N8f6cf8e7223e43c8a400f4e5c7117a35
54 schema:url http://link.springer.com/10.1007/BF01084370
55 sgo:license sg:explorer/license/
56 sgo:sdDataset articles
57 rdf:type schema:ScholarlyArticle
58 N0b5195102696497fabb3d83a39a5c320 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
59 schema:name Iodine Radioisotopes
60 rdf:type schema:DefinedTerm
61 N0e6879e4b16c4ba0be24687b59aab277 schema:name dimensions_id
62 schema:value pub.1013405250
63 rdf:type schema:PropertyValue
64 N0ffd3cd6fe644a72beaebcd13e246197 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
65 schema:name Dose-Response Relationship, Radiation
66 rdf:type schema:DefinedTerm
67 N16a91c07477842d5b01fbf8e33aaf1ca schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
68 schema:name Lymphoma, Non-Hodgkin
69 rdf:type schema:DefinedTerm
70 N1c4f47f2171d422b8f03c8237340f18d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
71 schema:name Thrombocytopenia
72 rdf:type schema:DefinedTerm
73 N250abead97a14b54afef74d90fd9e944 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
74 schema:name Platelet Count
75 rdf:type schema:DefinedTerm
76 N254e1cd2208e4825b669f65509a78cba schema:name pubmed_id
77 schema:value 8753685
78 rdf:type schema:PropertyValue
79 N30145b7544eb435fb3457a187ddfb58d schema:name doi
80 schema:value 10.1007/bf01084370
81 rdf:type schema:PropertyValue
82 N34cae762eb9c4f66a2dfe2024a9491c7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
83 schema:name Granulocytes
84 rdf:type schema:DefinedTerm
85 N3e9a134ab19a4d919cd8afe7377aa3a4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
86 schema:name Bone Marrow
87 rdf:type schema:DefinedTerm
88 N3f0b6b7223e445f192cc1fe1b85fef4c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
89 schema:name Leukemia, Lymphocytic, Chronic, B-Cell
90 rdf:type schema:DefinedTerm
91 N44d8548788064c4fae5efb434d99279e schema:volumeNumber 23
92 rdf:type schema:PublicationVolume
93 N44f58052b9264f93950d7e1bfea2612e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
94 schema:name Radioimmunotherapy
95 rdf:type schema:DefinedTerm
96 N45d3a2d3bf3e40259f4fc361fa7b4846 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
97 schema:name Humans
98 rdf:type schema:DefinedTerm
99 N5bcf7c9ea7114511ad803f1f8962d2f2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
100 schema:name Time Factors
101 rdf:type schema:DefinedTerm
102 N67e190e72a16445b97792aee0b410864 rdf:first sg:person.07427223257.57
103 rdf:rest Nf9678e115e7f45b78eea3ed453f1da3f
104 N7d91a97db9024526abf7233bcae51260 schema:name nlm_unique_id
105 schema:value 7606882
106 rdf:type schema:PropertyValue
107 N86cbe7b55dd841c080ff38589c548442 schema:name readcube_id
108 schema:value 3fdc86c4fb796d02169d96256b60dedac2b6c830aada1ae7e6a4ec55709ae0b3
109 rdf:type schema:PropertyValue
110 N894622ea46a2456c936645c997f72fe8 rdf:first sg:person.01135077736.53
111 rdf:rest rdf:nil
112 N8efd71083ecd4f8181d4cef23c3e74e2 schema:affiliation https://www.grid.ac/institutes/grid.413079.8
113 schema:familyName Sheri
114 schema:givenName Sui
115 rdf:type schema:Person
116 N8f2237e403ff4fb08fe21a8ef90525fc rdf:first sg:person.015350762352.16
117 rdf:rest Ne18c0565ee794b6d891571008218a00c
118 N8f6cf8e7223e43c8a400f4e5c7117a35 schema:name Springer Nature - SN SciGraph project
119 rdf:type schema:Organization
120 Na43594f076e54d0b9b5d9c8038f69ab6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
121 schema:name Leukocyte Count
122 rdf:type schema:DefinedTerm
123 Na51802e56b914af6807c40965b05800d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Linear Models
125 rdf:type schema:DefinedTerm
126 Nd59e0710947a4a50888b3c1ac373676a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
127 schema:name Agranulocytosis
128 rdf:type schema:DefinedTerm
129 Ne18c0565ee794b6d891571008218a00c rdf:first sg:person.01122351054.42
130 rdf:rest N894622ea46a2456c936645c997f72fe8
131 Ne7e9c8f11cfe48dbaeae81d0dd11183c schema:issueNumber 8
132 rdf:type schema:PublicationIssue
133 Nefcecbf3440c416fb36be28618fd525d rdf:first sg:person.01003154035.77
134 rdf:rest N67e190e72a16445b97792aee0b410864
135 Nf9678e115e7f45b78eea3ed453f1da3f rdf:first N8efd71083ecd4f8181d4cef23c3e74e2
136 rdf:rest N8f2237e403ff4fb08fe21a8ef90525fc
137 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
138 schema:name Medical and Health Sciences
139 rdf:type schema:DefinedTerm
140 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
141 schema:name Oncology and Carcinogenesis
142 rdf:type schema:DefinedTerm
143 sg:grant.2435561 http://pending.schema.org/fundedItem sg:pub.10.1007/bf01084370
144 rdf:type schema:MonetaryGrant
145 sg:journal.1297401 schema:issn 1619-7070
146 1619-7089
147 schema:name European Journal of Nuclear Medicine and Molecular Imaging
148 rdf:type schema:Periodical
149 sg:person.01003154035.77 schema:affiliation https://www.grid.ac/institutes/grid.416958.7
150 schema:familyName Wilder
151 schema:givenName Richard B.
152 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01003154035.77
153 rdf:type schema:Person
154 sg:person.01122351054.42 schema:affiliation https://www.grid.ac/institutes/grid.411841.9
155 schema:familyName Wessels
156 schema:givenName Barry W.
157 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01122351054.42
158 rdf:type schema:Person
159 sg:person.01135077736.53 schema:affiliation https://www.grid.ac/institutes/grid.413079.8
160 schema:familyName DeNardo
161 schema:givenName Sally J.
162 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01135077736.53
163 rdf:type schema:Person
164 sg:person.015350762352.16 schema:affiliation https://www.grid.ac/institutes/grid.412639.b
165 schema:familyName Fowler
166 schema:givenName John F.
167 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015350762352.16
168 rdf:type schema:Person
169 sg:person.07427223257.57 schema:affiliation https://www.grid.ac/institutes/grid.413079.8
170 schema:familyName DeNardo
171 schema:givenName Gerald L.
172 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07427223257.57
173 rdf:type schema:Person
174 sg:pub.10.1038/bjc.1986.16 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029332670
175 https://doi.org/10.1038/bjc.1986.16
176 rdf:type schema:CreativeWork
177 https://app.dimensions.ai/details/publication/pub.1076202820 schema:CreativeWork
178 https://app.dimensions.ai/details/publication/pub.1079799337 schema:CreativeWork
179 https://app.dimensions.ai/details/publication/pub.1079811328 schema:CreativeWork
180 https://app.dimensions.ai/details/publication/pub.1081838744 schema:CreativeWork
181 https://app.dimensions.ai/details/publication/pub.1082585424 schema:CreativeWork
182 https://doi.org/10.1002/1097-0142(19940201)73:3+<1038::aid-cncr2820731343>3.0.co;2-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010988824
183 rdf:type schema:CreativeWork
184 https://doi.org/10.1002/ijc.2910410819 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042188204
185 rdf:type schema:CreativeWork
186 https://doi.org/10.1016/0167-8140(90)90152-m schema:sameAs https://app.dimensions.ai/details/publication/pub.1029026126
187 rdf:type schema:CreativeWork
188 https://doi.org/10.1016/0360-3016(90)90467-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1044804676
189 rdf:type schema:CreativeWork
190 https://doi.org/10.1016/s0167-8140(85)80046-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041530437
191 rdf:type schema:CreativeWork
192 https://doi.org/10.1097/00003072-199502000-00005 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007371084
193 rdf:type schema:CreativeWork
194 https://doi.org/10.1097/00006231-199307000-00012 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028906005
195 rdf:type schema:CreativeWork
196 https://doi.org/10.1259/0007-1285-62-735-241 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064557430
197 rdf:type schema:CreativeWork
198 https://doi.org/10.1259/0007-1285-62-740-679 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064557601
199 rdf:type schema:CreativeWork
200 https://www.grid.ac/institutes/grid.411841.9 schema:alternateName George Washington University Hospital
201 schema:name Division of Radiation Oncology and Biophysics, George Washington University Medical Center, Washington, D.C., USA
202 rdf:type schema:Organization
203 https://www.grid.ac/institutes/grid.412639.b schema:alternateName UW Carbone Cancer Center
204 schema:name Departments of Human Oncology and Medical Physics, University of Wisconsin Clinical Cancer Center, Madison, Wisconsin, USA
205 rdf:type schema:Organization
206 https://www.grid.ac/institutes/grid.413079.8 schema:alternateName University of California Davis Medical Center
207 schema:name Department of Internal Medicine, University of California Davis Medical Center, Sacramento, California, USA
208 rdf:type schema:Organization
209 https://www.grid.ac/institutes/grid.416958.7 schema:alternateName UC Davis Health System
210 schema:name Department of Radiation Oncology, U.C. Davis Cancer Center, 4501 X St., Ste. G-126, 95817, Sacramento, CA, USA
211 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...